Session | Date |
---|---|
Molecular Tumor Board | 04/12/2024 - 1:00pm to 2:00pm CDT |
NRG1 Fusion Lung Adenocarcinoma | 02/23/2024 - 1:00pm to 2:00pm CST |
Colon cancer with high TMB and POLE mutation | 10/20/2023 - 1:00pm to 2:00pm CDT |
BRAF/MEK inhibitors in a MEK-mutated melanoma patient | 08/25/2023 - 1:00pm to 2:00pm CDT |